News
The Cancer Immunotherapy market, valued at USD 220.94 billion in 2024, is expected to register robust revenue CAGR of 13.6%.
Researchers are building on the success of CAR T therapy in blood cancers to explore its use in clear cell renal cell ...
Superior efficacy shown in two head-to-head phase III trials, including overall survival in DREAMM-7 Blenrep combinations ...
Cell models are replacing animal testing in pharma. Explore expert tips on transitioning to more accurate, ethical and ...
Market OverviewThe global Cancer Immunotherapy Market is valued at USD 121.4 Billion in 2024 and is projected to reach a ...
RSV compared to those who did not get BEYFORTUS, per new post-hoc analysis MORRISTOWN, N.J., July 22, 2025 /PRNewswire/ -- The largest US real-world study of BEYFORTUS (nirsevimab-alip) 50mg and 100mg ...
Popular GLP-1 drugs help many people drop tremendous amounts of weight, but the drugs fail to provide a key improvement in ...
Everyday Health on MSN5d
A New Treatment for Late-Stage Melanoma Uses the Power of the Herpesvirus
A new treatment for advanced melanoma is showing promising results for people whose tumors have stopped responding to ...
Popular GLP-1 drugs help many people drop tremendous amounts of weight, but the drugs fail to provide a key improvement in ...
News-Medical.Net on MSN2d
Muscle loss from GLP-1 drugs could undermine long-term health
Popular GLP-1 drugs help many people drop tremendous amounts of weight, but the drugs fail to provide a key improvement in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback